| Similar Articles |
|---|
 |
American Family Physician
December 1, 2005 |
Tuberculosis: What You Should Know A patient hand-out on the disease, who is susceptible, its treatment and medication recommendation.   |
Chemistry World
August 15, 2012 |
The latent threat of tuberculosis Although TB was close to being eradicated in the developed world, it is a major problem in developing countries. With drug-resistant strains on the increase, Clare Sansom outlines the latest in the fight against this killer disease |
HHMI Bulletin
Feb 2012
Nancy Ross-Flanigan |
A Safer Shot at TB While trying to understand tuberculosis bacteria genes, researchers discovered a safe way to shut down the bacteria. |
IEEE Spectrum
March 2010
Prachi Patel |
A World-beating TB Detector To quickly and cheaply diagnose the world's worst infectious disease, engineers have shrunk an NMR machine down to size |
Chemistry World
January 3, 2013
Andrew Turley |
TB drug milestone for bedaquiline Bedaquiline (sirturo) has become the first drug to be approved in the US for the treatment of multi-drug resistant tuberculosis |
Pharmaceutical Executive
November 1, 2014
Casey McDonald |
Advocacy Beat: Progress in Global Access to TB Drugs Treatment Action Group reaches a milestone in improving access to much-needed treatments for tuberculosis. |
Scientific American
February 2009
John Rennie |
Tuberculosis, The Unromantic Killer Tuberculosis has never stopped being one of the world's most lethal infections |
Pharmaceutical Executive
February 1, 2006
Joanna Breitstein |
Breath of Hope: TB in Africa For the first time in decades, the pharmaceutical industry has tuberculosis drugs in the pipeline. But it will take more than new pills to solve the problem. |
Wired
July 24, 2007
Thomas Goetz |
The Ultimate Diagnostic Device (By the Way, You've Got Drug-Resistant TB!) The CDC's goal of a tuberculosis-free society grew short due to the development of drug-resistant strains. But new standards for detection are in the works. |
Chemistry World
March 25, 2009
Hayley Birch |
TB's defence mechanism revealed The research could eventually lead to new drugs for TB, which remains one of the biggest killers among infectious diseases worldwide. |
Pharmaceutical Executive
September 1, 2011 |
The Power of PDP Can cooperative ties between Big Pharma, NGOs, government, and international organizations pay the freight in making the fight against neglected diseases a permanent fix in global health? |
Popular Mechanics
January 8, 2010
Erin McCarthy |
How to Stop a Daybreakers-Style Vampire Epidemic As far-fetched as the "disease" may be, there are certain steps doctors, scientists and officials always take when analyzing an outbreak. |
Pharmaceutical Executive
September 1, 2011 |
Filling Front and Center in the Fight against TB Dr. Mel Spigelman, President and CEO of the TB Alliance, discusses the organization's priorities in developing treatments for tuberculosis. |
HHMI Bulletin
Aug 2010 |
Bishai Named Director of K-RITH A prominent tuberculosis researcher and doctor will become the first permanent director of the KwaZulu-Natal Research Institute for Tuberculosis and HIV. |
AskMen.com
Jacob Franek |
4 Future Plagues What future plagues await us? Let's have a look. |
AskMen.com
Jacob Franek |
Airplane Air As if the fear of terrorism, turbulence or mechanical failure were not enough, airplane passengers still have to contend with the fear of microbial invasion. |
Chemistry World
March 6, 2011
Laura Howes |
Sensitive TB diagnosis using sugar For the first time, tuberculosis can be detected and tracked through the body, using a simple sugar based molecule. |
Chemistry World
November 28, 2008
Hayley Birch |
Drug detonates nitric oxide inside tuberculosis bacteria US and Singaporean scientists have discovered how a promising anti-tuberculosis drug, PA-824, triggers an explosive chain of events inside its target bacterial cells. |
Fast Company
Christina Farr |
AHA, Alphabet Set Aside $75 Million To Cure Coronary Heart Disease The American Heart Association, Verily (the company formerly known as Google Life Sciences), and European pharmaceutical giant AstraZeneca are investing the funds over a five-year period. |
Bio-IT World
Jul/Aug 2006
Robert M. Frederickson |
Tests for Hospital-Acquired Infections Tests for pathogens increasingly rely on genomic methods that identify specific genetic signatures of bacteria or viruses. Rapid detection of other pathogens also provides the potential for significant impact on the healthcare industry. |
American Family Physician
November 15, 2000 |
Clinical Briefs Reducing Falls Among Older Women... Physical Activity and Fitness in Schools... Exercise in the Patient with Diabetes Mellitus... Blueprint for Development of Tuberculosis Vaccine... Answers to This Issues' Clinical Quiz... |
Chemistry World
October 29, 2015
Anthony King |
Poor diagnostics hinder battle against antibiotic resistance The tools used to diagnose bacterial infections have barely improved since the 1940s. |
The Motley Fool
June 29, 2009
Brian Orelli |
Funding From an Unlikely Place Nonprofits still have money, and they seem willing to fork it over to for-profit drug companies. |
Chemistry World
May 12, 2011
Mike Brown |
Sugars recruited in fight against persistent infections Adding sugar to antibiotics can boost their effectiveness and prevent recurrent and chronic infections, according to researchers in the US. |
